A Family Requests Predictive Testing for a Child with a Metabolic Condition
Parents of a 7-year-old boy with a confirmed autosomal recessive metabolic disorder (a treatable amino acidopathy) request predictive genetic testing for their 5-year-old daughter, who is asymptomatic. They say they want to 'know now' so they can start treatment early if needed, and they are anxious because a cousin was diagnosed late with severe consequences. The daughter's newborn screen was normal, but the parents do not trust it. The family is from a community with limited access to metabolic specialists, and the parents are the decision-makers for both children.
1. What are the ethical considerations around predictive testing in this asymptomatic child, and how do you weigh them?
Read the worked answer
Ethical considerations:
- Best interests of the child: Predictive testing for a childhood-onset, treatable condition can be justified if early detection would change management and prevent harm. Here the disorder is treatable, so there is a potential benefit.
- Autonomy and future choice: For adult-onset or untreatable conditions, predictive testing is generally deferred until the child can consent. For a treatable childhood condition, the balance shifts toward benefit.
- Parental authority vs. child's rights: Parents generally may consent for their minor children, but testing should serve the child's medical interests, not parental anxiety alone.
- Psychosocial harms: A positive result can cause labeling, anxiety, and altered family expectations; a negative result can cause survivor guilt or false reassurance.
- Confidentiality and insurance: Genetic information has privacy implications; discuss how results are stored and shared.
Weighing: Because the condition is treatable and childhood-onset, testing the daughter is ethically defensible if it would lead to monitoring or treatment that prevents harm. However, the parents' motivation ('start treatment early') should be examined: if the child is asymptomatic and the newborn screen was normal, the probability of affected status is low, and testing may not change management. The cousin's late diagnosis is a legitimate concern but does not by itself justify testing without a clear benefit.
Key point: the decision hinges on whether a result would change management for this child.
2. How do you counsel the parents, and what do you recommend regarding testing the daughter?
Read the worked answer
Counseling:
- Acknowledge their anxiety and the cousin's experience; validate their wish to protect their daughter.
- Explain the genetics: autosomal recessive inheritance means each child has a 25% chance of being affected if both parents are carriers; the daughter's normal newborn screen reduces but does not eliminate the chance (screening can miss mild or late-onset forms).
- Explain that the brother's diagnosis allows targeted testing (known familial variants), which is more informative than the newborn screen.
- Discuss what testing would and would not tell them: a positive result would prompt monitoring and treatment; a negative result would provide reassurance but does not guarantee absence of other conditions.
- Discuss the child's future autonomy: for a treatable childhood condition, testing can be justified, but the child should be involved in an age-appropriate way, and results should be disclosed to her over time.
Recommendation: Offer targeted testing for the known familial variants after genetic counseling, with the understanding that it is being done for the child's medical benefit. If the family prefers to wait, that is also reasonable given the normal newborn screen and asymptomatic status; provide a monitoring plan and clear triggers to seek care. Document the discussion and the family's decision.
Key point: shared decision-making with a clear medical rationale, not parental anxiety alone.